{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:34:33Z","timestamp":1790397273124,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health (US) Bench-to-Bedside Award","award":["10-2103"],"award-info":[{"award-number":["10-2103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0848-9","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T05:30:18Z","timestamp":1530595818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-9998","authenticated-orcid":false,"given":"Jessica W.","family":"Witherspoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhi P.","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Waite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene C.","family":"Chrismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Wakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal S.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G.","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine G.","family":"Meilleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"848_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","volume":"70","author":"K Amburgey","year":"2011","unstructured":"Amburgey K, McNamara N, Bennett LR, McCormick ME, Acsadi G, Dowling JJ. Prevalence of congenital myopathies in a representative pediatric United States population. Ann Neurol. 2011;70:662\u20135.","journal-title":"Ann Neurol"},{"key":"848_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.nmd.2014.05.003","volume":"24","author":"MA Illingworth","year":"2014","unstructured":"Illingworth MA, Main M, Pitt M, et al. RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscul Disord. 2014;24:707\u201312.","journal-title":"Neuromuscul Disord"},{"key":"848_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","volume":"18","author":"H Jungbluth","year":"2011","unstructured":"Jungbluth H, Sewry CA, Muntoni F. Core myopathies. Semin Pediatr Neurol. 2011;18:239\u201349.","journal-title":"Semin Pediatr Neurol"},{"key":"848_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling JJ, Arbogast S, Hur J, et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain. 2012;135:1115\u201327.","journal-title":"Brain"},{"key":"848_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2990.2010.01149.x","volume":"37","author":"JA Bevilacqua","year":"2011","unstructured":"Bevilacqua JA, Monnier N, Bitoun M, et al. Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol Appl Neurobiol. 2011;37:271\u201384.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"848_CR6","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awm096","volume":"130","author":"H Zhou","year":"2007","unstructured":"Zhou H, Jungbluth H, Sewry CA, et al. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain. 2007;130:2024\u201336.","journal-title":"Brain"},{"key":"848_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","volume":"80","author":"BM Kluger","year":"2013","unstructured":"Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013;80:409\u201316.","journal-title":"Neurology"},{"key":"848_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00018-009-0184-2","volume":"67","author":"JM de Vries","year":"2010","unstructured":"de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA. Fatigue in neuromuscular disorders: focus on Guillain-Barre syndrome and Pompe disease. Cell Mol Life Sci. 2010;67:701\u201313.","journal-title":"Cell Mol Life Sci"},{"key":"848_CR9","first-page":"685","volume":"59","author":"K Kumor","year":"2006","unstructured":"Kumor K, Pierzchala K. The problem of fatigue in neurological disorders. Wiad Lek. 2006;59:685\u201391.","journal-title":"Wiad Lek"},{"key":"848_CR10","first-page":"1018","volume":"2","author":"A Arafah","year":"2015","unstructured":"Arafah A, Kuspinar A, Mayo N. Untangling perception of fatigue and fatigability: first steps. Austin J Multiple Sclerosis Neuroimmunology. 2015;2:1018\u201325.","journal-title":"Austin J Multiple Sclerosis Neuroimmunology"},{"key":"848_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1212\/WNL.0000000000002332","volume":"86","author":"LK Andersen","year":"2016","unstructured":"Andersen LK, Knak KL, Witting N, Vissing J. Two- and 6-minute walk tests assess walking capability equally in neuromuscular diseases. Neurology. 2016;86:442\u20135.","journal-title":"Neurology"},{"key":"848_CR12","first-page":"1070","volume-title":"Neuromuscular disorders of infancy, childhood, and adolescence","author":"N Strauss","year":"2015","unstructured":"Strauss N, Montes J, Russman B, et al. Rehabilitation of the child with a neuromuscular disorder. In: Darras B, editor. Neuromuscular disorders of infancy, childhood, and adolescence. 2nd ed. Oxford: Elsevier; 2015. p. 1070\u201389. eds.","edition":"2"},{"key":"848_CR13","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1428\u201346.","journal-title":"Eur Respir J"},{"key":"848_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATSCPSCPF Laboratories","year":"2002","unstructured":"Laboratories ATSCPSCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"848_CR15","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/hmg\/9.18.2599","volume":"9","author":"N Monnier","year":"2000","unstructured":"Monnier N, Romero NB, Lerale J, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet. 2000;9:2599\u2013608.","journal-title":"Hum Mol Genet"},{"key":"848_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-2-31","volume":"2","author":"H Jungbluth","year":"2007","unstructured":"Jungbluth H. Multi-minicore Disease. Orphanet J Rare Dis. 2007;2:31.","journal-title":"Orphanet J Rare Dis"},{"key":"848_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.rmed.2006.01.001","volume":"100","author":"A Chetta","year":"2006","unstructured":"Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med. 2006;100:1573\u20138.","journal-title":"Respir Med"},{"key":"848_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","volume":"158","author":"PL Enright","year":"1998","unstructured":"Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"848_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","volume":"150","author":"R Geiger","year":"2007","unstructured":"Geiger R, Strasak A, Treml B, et al. Six-minute walk test in children and adolescents. J Pediatr. 2007;150:395\u20139. 399 e1\u20132","journal-title":"J Pediatr"},{"key":"848_CR20","doi-asserted-by":"publisher","first-page":"e84120","DOI":"10.1371\/journal.pone.0084120","volume":"8","author":"N Goemans","year":"2013","unstructured":"Goemans N, Klingels K, van den Hauwe M, et al. Six-minute walk test: reference values and prediction equation in healthy boys aged 5 to 12 years. PLoS One. 2013;8:e84120.","journal-title":"PLoS One"},{"key":"848_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nmd.2013.05.006","volume":"23","author":"N Goemans","year":"2013","unstructured":"Goemans N, van den Hauwe M, Wilson R, van Impe A, Klingels K, Buyse G. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul Disord. 2013;23:618\u201323.","journal-title":"Neuromuscul Disord"},{"key":"848_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1750-1172-8-160","volume":"8","author":"R Lachmann","year":"2013","unstructured":"Lachmann R, Schoser B. The clinical relevance of outcomes used in late-onset Pompe disease: can we do better? Orphanet J Rare Dis. 2013;8:160.","journal-title":"Orphanet J Rare Dis"},{"key":"848_CR23","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.rehab.2016.07.100","volume":"59S","author":"F Kopciuch","year":"2016","unstructured":"Kopciuch F. Walking fatigability in multiple sclerosis: a comparison between the 2- and the 6-minute walk test and an evaluation of associated factors. Ann Phys Rehabil Med. 2016;59S:e43.","journal-title":"Ann Phys Rehabil Med"},{"key":"848_CR24","doi-asserted-by":"crossref","unstructured":"Jordan B, Mehl T, Schweden TL, Menge U, Zierz S. Assessment of physical fatigability and fatigue perception in myasthenia gravis. Muscle Nerve. 2017;55:657\u2013663.","DOI":"10.1002\/mus.25386"},{"key":"848_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mus.23905","volume":"48","author":"CM McDonald","year":"2013","unstructured":"McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48:357\u201368.","journal-title":"Muscle Nerve"},{"key":"848_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jep.12158","volume":"20","author":"RW Bohannon","year":"2014","unstructured":"Bohannon RW, Glenney SS. Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review. J Eval Clin Pract. 2014;20:295\u2013300.","journal-title":"J Eval Clin Pract"},{"key":"848_CR27","doi-asserted-by":"publisher","first-page":"s273","DOI":"10.1016\/j.nmd.2015.06.316","volume":"25","author":"KL Knak","year":"2015","unstructured":"Knak KL, Andersen L, Witting N, Vissing J. Test-retest reliability of the 2- and 6-minute walk tests in patients with neuromuscular diseases. Neuromuscul Disord. 2015;25:s273.","journal-title":"Neuromuscul Disord"},{"key":"848_CR28","doi-asserted-by":"publisher","first-page":"e114273","DOI":"10.1371\/journal.pone.0114273","volume":"9","author":"KP Prahm","year":"2014","unstructured":"Prahm KP, Witting N, Vissing J. Decreased variability of the 6-minute walk test by heart rate correction in patients with neuromuscular disease. PLoS One. 2014;9:e114273.","journal-title":"PLoS One"},{"key":"848_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1756-0500-7-269","volume":"7","author":"RW Bohannon","year":"2014","unstructured":"Bohannon RW, Bubela D, Magasi S, et al. Comparison of walking performance over the first 2 minutes and the full 6 minutes of the six-minute walk test. BMC Res Notes. 2014;7:269.","journal-title":"BMC Res Notes"},{"key":"848_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.gaitpost.2016.06.007","volume":"49","author":"G Reychler","year":"2016","unstructured":"Reychler G, Debatisse M, Lebecque P, Pieters T, Liistro G, Gohy S. Variability of gait speed during six minutes walking test in COPD and cystic fibrosis patients. Gait Posture. 2016;49:36\u201340.","journal-title":"Gait Posture"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0848-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:24:16Z","timestamp":1562095456000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0848-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0848-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study (NCT02362425) and consent\/assent forms were approved by the Institutional Review Board of the National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"105"}}